Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
5 reports, 2 independent
Updated Oct 11
Gone quiet
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA approved Weltruza sale; Ding raised Teva stock price target.1 source
Truist Financial raised its target price on Teva stock.1 source
Keep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
Nothing else this week.
Related events
- Truist Financial lifted its price target and Jefferies Financial Group reissued a buy rating for Pediatrix Medical Group.
- Truist Financial and Raymond James Financial raised price targets for First Bancorp on July 1, 2026.
- Truist Financial raised its target price on Avient, while Norges Bank purchased a new stake in the company.
- Truist Financial cut its price target and lowered its rating, while TD Cowen raised its target price, with MarketBeat aggregating consensus ratings.
- Leerink Partners, Truist Financial, HSBC, and Cantor Fitzgerald raised target prices on various stocks on October 9, 2026.